CPL-409116

N/A

Report date: 2024/02/04 13:28:13
NME

Base Information

Drug NameCPL-409116
Drug Alias NameCPL-116CPL'116
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitorsRho-associated kinases inhibitors
TargetsJanus kinaseRho-associated kinases
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkrainePoland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCelon Pharma Sa
China Registration ClassN/A

Develop Information

Active CompaniesCelon Pharma Sa
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A